Application 020668

Type
NDA
Sponsor
ASTRAZENECA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEXXELENALAPRIL MALEATE; FELODIPINETABLET, EXTENDED RELEASE;ORAL5MG;5MGNoNo
002LEXXELENALAPRIL MALEATE; FELODIPINETABLET, EXTENDED RELEASE;ORAL5MG;2.5MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020668-001LEXXELENALAPRIL MALEATE; FELODIPINE5MG;5MGTABLET, EXTENDED RELEASE / ORAL1996-12-27
N020668-002LEXXELENALAPRIL MALEATE; FELODIPINE5MG;2.5MGTABLET, EXTENDED RELEASE / ORAL1998-10-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N020668-001LEXXEL5MG;5MGTABLET, EXTENDED RELEASE / ORAL1996-12-27f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N020668-002LEXXEL5MG;2.5MGTABLET, EXTENDED RELEASE / ORAL1998-10-28f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020668-001LEXXEL5MG;5MGTABLET, EXTENDED RELEASE / ORAL1996-12-27e64feba35796…
2022-09-29 23:25 UTC2022-09N020668-002LEXXEL5MG;2.5MGTABLET, EXTENDED RELEASE / ORAL1998-10-28e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020668-001LEXXEL5MG;5MGTABLET, EXTENDED RELEASE / ORAL1996-12-27cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020668-002LEXXEL5MG;2.5MGTABLET, EXTENDED RELEASE / ORAL1998-10-28cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N020668-001LEXXEL5MG;5MGTABLET, EXTENDED RELEASE / ORAL1996-12-27a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N020668-002LEXXEL5MG;2.5MGTABLET, EXTENDED RELEASE / ORAL1998-10-28a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
20812SUPPL2008-02-19
3051SUPPL2007-10-10
41535SUPPL2007-07-06
20810SUPPL2007-07-06
13177SUPPL2005-08-04
3048SUPPL2005-08-04
3050SUPPL2004-12-29
25483SUPPL2004-06-10
13178SUPPL2004-06-10
3049SUPPL2003-06-22
20811SUPPL2002-07-25
35119SUPPL1998-10-28
3047SUPPL1998-10-28